Chronic Inflammatory Rheumatism: Management of Comorbidities in Ambulatory Medicine

NCT05613712 | Completed

• 1 other identifier: 38RC22.0355
• Study Type: observational
• Target: 229
• Locations: 1 country
• Sites: 1

Brief Summary

Identification of factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes

Conditions

Chronic Inflammatory Disease

Keywords

rheumatoid arthritis; spondyloarthropathy; spondylarthritis; ankylosing spondylitis; psoriatic arthritis; chronic inflammatory rheumatic diseases; comorbidities; continuity of patient care; patient compliance; adherence; non-adherence

Outcome Measures

Primary Outcomes (1)

• Identification of the factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes, through questionnaires

  Identification of the factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes

  1 day

Secondary Outcomes (2)

• Elements limiting the good ambulatory follow-up, according to the patients

  1 day

• Elements limiting the applicability of the recommendations issued by the rheumatology department of the CHU Grenoble Alpes, according to the patients

  1 day

Study Arms (2)

Patients

Patients followed by the rheumatology department of the CHU Grenoble Alpes, constituting the SCORIC group

Other: Patients

Referring physician

Physicians identified as the referring physician for patients in the SCORIC group

Other: Referring physician

Interventions

Patients OTHER

Description by the patients through the questionnaire of the elements limiting the good ambulatory follow-up

Patients

Referring physician OTHER

Description by the referring physicians through the questionnaire of the elements limiting the applicability of the recommendations issued by the rheumatology department of the CHU Grenoble Alpes

Referring physician

Eligibility Criteria

• Age: 18 Years - 90 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The SCORIC population targeted by the patient questionnaire represents all patients followed by the rheumatology department of the CHU Grenoble Alpes, having benefited from a holistic analysis of their disease and their comorbidities. The referring physician population will be generated from the medical records of the patients of the SCORIC cohort.

You may qualify if:

• Patient cohort :
• men and women over 18 years of age
• Informed volunteers who have consented to participate in the study
• have rheumatoid arthritis, spondyloarthritis or psoriatic arthritis
• have been hospitalised in a day hospital in the rheumatology department of the Grenoble-Alpes University = SCORIC cohort of the department
• Cohort of referring physicians :
• volunteers who received informed information and consented to participate in the study
• be the referring physician of a patient of the SCORIC cohort of the rheumatology department of the South Hospital of the CHU Grenoble-Alpes

You may not qualify if:

• Patient cohort :
• psychiatric pathologies or history of behavioural disorders
• persons referred to in articles L1121-5 to L1121-8 of the Public Health Code
• persons under guardianship or curatorship
• not affiliated to the social security system
• minors
• Refusal to participate by the patient and/or unreturned questionnaire
• Cohort of referring physicians:
• the physician is no longer the patient's referring physician
• refusal of the doctor to participate and/or questionnaire not returned

Sponsors & Collaborators

• University Hospital, Grenoble: lead

Study Sites (1)

CHU Grenoble Alpes

Grenoble, 38043, France

Location

Related Publications (1)

• Lagadou A, Gastaldi R, Vacher L, Baillet A. Gender influences adhesion to recommendations for optimal comorbidity screening and management of patients with chronic inflammatory rheumatic diseases starting a biological disease-modifying antirheumatic drug. RMD Open. 2024 Nov 11;10(4):e004364. doi: 10.1136/rmdopen-2024-004364. No abstract available.

  PMID: 39532462 RESULT

MeSH Terms

Conditions

Arthritis, Rheumatoid; Spondylarthropathies; Spondylarthritis; Spondylitis, Ankylosing; Arthritis, Psoriatic; Patient Compliance

Condition Hierarchy (Ancestors)

Arthritis; Joint Diseases; Musculoskeletal Diseases; Rheumatic Diseases; Connective Tissue Diseases; Skin and Connective Tissue Diseases; Autoimmune Diseases; Immune System Diseases; Spondylitis; Spinal Diseases; Bone Diseases; Axial Spondyloarthritis; Ankylosis; Psoriasis; Skin Diseases, Papulosquamous; Skin Diseases; Patient Acceptance of Health Care; Treatment Adherence and Compliance; Health Behavior; Behavior

Study Officials

• Xavier ROMAND, PHD

  CHU Grenoble Alpes

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 4, 2022
• First Posted: November 14, 2022
• Study Start: February 11, 2023
• Primary Completion: May 4, 2023
• Study Completion: May 4, 2023
• Last Updated: December 29, 2025

Record last verified: 2025-12

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)